Johns Hopkins
Quest Diagnostics to Acquire Liquid Biopsy Firm Haystack Oncology for up to $450M
The lab testing giant will add Haystack's minimal residual disease technology to its suite of genomic and other clinical services.
Kephera Diagnostics Gets $3M NIH Grant for Chagas Disease Test
The company previously received nearly $600,000 from the NIH to work on the test, which it now intends to validate in clinical studies in the US and Latin America.
Liver Cancer Detection Score Developed With Machine Learning Analysis of Blood Plasma DNA Fragments
Researchers used machine learning to come up with a cell-free DNA 'fragmentome'-based score for finding hepatocellular carcinoma cases from blood plasma samples.
The company is aiming to launch clinical testing services by the second half of next year, using a high-sensitivity, patient-personalized assay technology.
Liquid Biopsy Startup Haystack Oncology Raises $56M in Series A Round
The company was spun out of Johns Hopkins last year to commercialize a circulating tumor DNA-detection technology for minimal residual disease testing.